Scientists test new 'Long-Lasting' breast cancer drug shot in healthy volunteers
NCT ID NCT06315205
Summary
This is an early-stage study to learn about the safety and how the body processes a new, long-acting injectable form of the drug letrozole. It involves about 90 healthy post-menopausal women who will receive a single injection at different dose levels. The main goal is to gather initial data on how long the drug stays in the body and to check for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site number CZ-01
Prague, Czechia
Conditions
Explore the condition pages connected to this study.